What AESEG does

AESEG (Asociación Española de Medicamentos Genéricos) is the Spanish trade association representing manufacturers of generic medicines, founded in March 1998 in Barcelona and headquartered at Calle Diego de León 22 in Madrid. The association is a non-profit patronal organization that acts as the unified voice of the Spanish generic pharmaceutical industry, claiming coverage of nearly 90% of the market through its member companies, which include leading manufacturers such as KERN Pharma, Sandoz, Teva, Cinfa, Ratiopharm, Stada, Merck Genéricos, Alter, and Mabo-Farma. AESEG does not develop proprietary technology or sell commercial products; rather, it operates through industry advocacy, regulatory engagement, and stakeholder communication.

Its core activities center on policy advocacy at both Spanish (AEMPS, Ministry of Health, regional CCAA) and European (Medicines for Europe, European Parliament) levels, participation in sector infrastructure such as SEVeM (Spanish Medicines Verification System) and SIGRE (pharmaceutical packaging waste management), and the production of content assets including the Revista en Genérico journal, the En Genérico blog, and an award-winning corporate website. The association highlights industry contributions to the Spanish healthcare system: generic medicines generate over €1 billion in annual savings and €10.5 billion in cumulative savings over the past decade, support 6,500 direct and 26,000 indirect jobs, and account for 3.53% of industry turnover reinvested in R&D.

AESEG is funded by membership dues from its member companies rather than commercial revenue. Governance rests with a Board of Directors elected by the General Assembly, with a senior executive team led by Secretary General Elena Casaus Lara and Director General Ángel Luis Rodríguez de la Cuerda, and presidencies historically held by CEOs of major member laboratories (Raúl Díaz-Varela of KERN Pharma, Juan Luis Fernández Balaguer of Sandoz, Guillermo Tena Suriani of Mabo-Farma). Its primary customers are its member companies, while its broader stakeholder constituencies include healthcare professionals, patients, and Spanish public administration.

Name

AESEG

Legal name

AESEG - Asociación Española de Medicamentos Genéricos

Website

https://aeseg.es

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

1–10 employees

Short description

AESEG is the Spanish non-profit trade association representing nearly 90% of the country's generic pharmaceutical manufacturers, founded in 1998 and headquartered in Madrid. It advocates for the generic medicines industry with Spanish and EU regulators, participates in supply-chain integrity systems, and communicates sector data to policymakers, healthcare professionals, and the public.

Ownership category

akta.pro rank

Headquarters

HQ city

Madrid

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Others

Distribution channels1 record

Marketing channels7 records

Core offering

AESEG is a non-profit trade association (patronal) representing nearly 90% of Spain's generic pharmaceutical industry. It advocates for favorable regulatory frameworks, promotes generic medicines adoption, and supports the sustainability of the Spanish National Health System through policy coordination, regulatory affairs representation, member services, and participation in sector infrastructure such as SEVeM (medicines verification) and SIGRE (environmental management of pharmaceutical packaging).

Product overview

AESEG is a trade association (patronal) representing the generic medicines industry in Spain, not a product company. It does not offer commercial products or services. Its activities include industry advocacy, policy representation, publishing (Revista en genérico magazine), operating a blog (En genérico), and participating in sector initiatives like SEVeM (medication verification) and SIGRE (environmental management of pharmaceutical packaging).

Differentiator

Problem solved

Functional benefit

Brands

• Revista en Genérico: AESEG's magazine/publication covering topics related to generic medicines, sustainability, and industry news. Published periodically with Issue 42 released in January 2026.
• Blog En Genérico

Products and services

• Revista en Genérico

Quantifiable outcome

• Over 1,000 million euros in annual savings generated by generic medicines for the Spanish healthcare system
• +2 more outcomes

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered core and minor.

• Medicines for EuropecoreStrategic or Co-development PartnerAESEG is a member of Medicines for Europe (formerly EGA - European Generic Medicines Association), the European umbrella organization representing the generic medicines industry. This partnership provides AESEG with European-level advocacy, policy coordination, and industry representation at the EU institutions.
• SEVeM (Sistema Español de Verificación de Medicamentos)coreStrategic or Co-development PartnerAESEG participates actively in SEVeM, the Spanish Medicines Verification System, which guarantees that each dispensed pack in Spain is authentic, safe, and controlled. SEVeM was created under EU legislation against falsification of medicines and allows verification of drug authenticity throughout the supply chain.
• SIGREcoreStrategic or Co-development PartnerAESEG is part of SIGRE (Sistema Integrado de Gestión de Residuos de Envases), a non-profit entity responsible for ensuring proper environmental management of packaging and medicine residues generated in households. SIGRE was established in 2001 through collaboration between the pharmaceutical industry, pharmacies, and distribution companies. Generic medicine companies finance approximately 50% of this entity.
• Spanish pharmaceutical sector associations (Aelmhu, Anefp, AseBio, BioSim, Farmaindustria, Stanpa)minorStrategic or Co-development PartnerJoint statement with other Spanish pharmaceutical and cosmetics sector associations regarding the EU Urban Wastewater Treatment Directive, sharing the environmental objective of the regulation while opposing disproportionate cost burdens on the industry.

Scale indicators12 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Farmaindustria: Spanish trade association representing the innovative (branded) pharmaceutical industry. Direct peer in terms of structure (national pharma patronal) and scope (advocacy for pharma sector in Spain), though representing branded rather than generic manufacturers.
• AESGP (Association of the European Self-Care Industry): European association representing manufacturers of non-prescription medicines, food supplements, and self-care products. Adjacent peer sharing European policy advocacy role and membership-based structure.
• IGBA (International Generic and Biosimilar Medicines Association): International umbrella association for generic and biosimilar medicines manufacturers worldwide. Peer to AESEG's parent body Medicines for Europe; comparable in mission to promote generic and biosimilar medicines globally.
• Medicines for Europe: European umbrella organization (formerly EGA) representing the generic medicines industry across Europe. AESEG is a founding member; this is the most direct functional peer as both advocate for generic pharma policy at national and EU level.
• AseBio: Spanish Bioindustry Association representing biotechnology companies in Spain. Direct peer in structure (Spanish pharma/life science patronal) and joins AESEG in joint policy positions such as the EU Wastewater Directive statement.
• BGMA (British Generic Manufacturers Association): UK trade association for generic medicines manufacturers. Direct functional peer to AESEG, advocating for the British generic pharma sector with similar national-level policy and NHS cost-containment focus.
• CGPA (Canadian Generic Pharmaceutical Association): Canadian trade association for generic pharmaceutical manufacturers. Direct functional peer to AESEG, advocating for the Canadian generic pharma sector with similar healthcare cost-containment value proposition.
• Pro Generika: German trade association for generic medicines manufacturers. Highly comparable in mission, structure, and activities to AESEG, representing German generic pharma companies with national and EU advocacy focus.

Regional players

• EGA Egypt (Egyptian Generic Medicines Association): National trade association for generic pharmaceutical manufacturers in Egypt. Comparable in mission and structure to AESEG but operating in a different geographic market with focus on MENA region.
• AEFI (Asociación Española de Farmacéuticos de la Industria): Spanish association of industrial pharmacists. AESEG regularly participates in AEFI Symposium events; comparable as Spanish pharmaceutical industry association with overlapping member companies.

Market position

Strengths4 records

Weaknesses2 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/c/AESEGMedicamentosGenéricos
• LinkedInlinkedin.com/company/aeseg

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AESEG